Biotech Values

[Rocky3]

You were much too high—it will be $15-18M per quarter, according to today’s CC.

A little apples and oranges here.

They are talking about "net" after non-mLov revenue. I still think my number will right (at end of '11) for "gross" overhead. I was using a too low number for other revenue.

Clearly the net number is the most important. At 15-18/qtr, that still produces a 60-72 number that MNTA needs from mLov to be cash flow flat, and that number is unlikely if tLov is approved (which I hope never happens). Even if there is cash flow deficit, it will not be gigantic and will be able to be funded from cash on the balance sheet until mCop comes in '14-'15, if not sooner.

JMO.